Befejeződött1. fázis
A study investigating the effect of different approved medications on how the body processes the study compound RO7795081. RO7795081 is a new compound that may potentially be used in the treatment of type 2 diabetes and weight control.
Key facts
- Where
- Groningen, HollandiaSee the site
- Phase
- 1. fázis
Where in Hollandia
- Pharma Bio-Research GroupGroningen, HollandiaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- F. Hoffmann-La Roche AG
- Trial code
- EU 2024-517360-37-00
- Record updated
- 2025. április 18.